IL6 and acute myeloid leukemia: IL-6 secreted by leukaemic cells also activates STAT3 signalling, further triggers the oxidative phosphorylation metabolic pathway [52], and promotes CD36 expression, CD36-mediated uptake of fatty acids, and AML blast chemoresistance against Ara-c [87].